Elizabeth A. Barrett, Chief Executive Officer at UroGen Pharma Ltd. (URGN), sold 93,936 shares at $9.15 ($860K) on 2022-01-04, disclosed to the SEC on 2022-01-07.
Open-market sale of $860k URGN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.15 | 46,968 | $430K | 50.0% |
| 2 | $9.15 | 46,968 | $430K | 50.0% |
| Total | $9.15 avg | 93,936 | $860K | 100% |
| Filing → |
| URGN | BUY | 2019-11-22 | $209K | — | Filing → |
| URGN | BUY | 2019-11-22 | $211K | — | Filing → |
| URGN | BUY | 2019-11-18 | $40K | — | Filing → |